Clinical trial
Prospective Randomized Study Evaluating the Effect of Postoperative Ketorolac on Bone Healing and Opioid Consumption After First Metatarsophalangeal Joint Fusion
NCT04872283 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Study Evaluating the Effect of Postoperative Ketorolac on Bone Healing and Opioid Consumption After First Metatarsophalangeal Joint Fusion
- Lead sponsor
- Rothman Institute Orthopaedics
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 23, 2019
- Completion date
- December 31, 2021
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
joint fusion, ketorolac